March 29, 2018
Rose
“We took a first step toward transparency, but it wasn’t substantial enough to give us anything of true value," said Vermont state lawmaker William Lippert. In other news FDA Commissioner Scott Gottlieb wants to get biosimilars to the market faster, and Democrats prepare to use high drug prices as a campaign message.
from Kaiser Health News https://ift.tt/2pOaYwe
March 29, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: New York Inmates With Mental Illness Have Extended Stays, Suit Alleges; Colorado Governor Opens Office To Curb Health Care Costs- There Were Horrified Researchers Who Knew About Scientist’s Embryo Gene-Editing Plans, But They Had Nowhere To Turn
- Trump Administration Rules Foster Program That Only Works With Heterosexual Couples Can Receive Federal Funding
- As Families Scramble To Find Good Treatment Programs During Opioid Epidemic, Addiction Specialists Offer Guidelines
- Eating Fried Foods Linked To Heart Disease, Earlier Deaths In Women Over 50
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment